Acute stroke (within 30‐days after surgery: new focal neurologic deficit with signs and symptoms lasting longer than 24 hours) · adults undergoing non‐cardiac surgery
1 finding from 1 review
Relapse · patients with schizophrenia
It is very uncertain whether ORAL FLUPHENAZINE changes global state: Relapse ‐ long termClinical judgement compared with PLACEBO (very low certainty).
1 finding from 1 review
Adverse effects: Death ‐ long termOccurrences of death · patients with schizophrenia
ORAL FLUPHENAZINE showed no clear difference in adverse effects: Death ‐ long termOccurrences of death compared with PLACEBO (low certainty).
1 finding from 1 review
Adverse events experienced at short or long term ‐ Serious cardiovascular adverse events ‐ bradycardia 24 weeks' · infantile haemangiomas (strawberry birthmarks) of the skin
1 finding from 1 review
Adverse events experienced at short or long term ‐ general adverse events 24 weeks' · infantile haemangiomas (strawberry birthmarks) of the skin
It is very uncertain whether oral propranolol changes adverse events experienced at short or long term ‐ general adverse… compared with topical timolol (very low certainty).
1 finding from 1 review
Adverse events experienced at short or long term ‐ Serious adverse events 24 weeks' · infantile haemangiomas (strawberry birthmarks) of the skin
Oral propranolol showed no clear difference in adverse events experienced at short or long term ‐ Serious adverse… compared with placebo (low certainty).
1 finding from 1 review
Relapse · patients with schizophrenia
COMPARISON 1: CBT+ STANDARD CARE showed no clear difference in global state: 1a. Relapse ‐ long term compared with STANDARD CARE ALONE (low certainty).
1 finding from 1 review
Global state: 2. Clinically important change (no improvement) ‐ long term · patients with schizophrenia
It is very uncertain whether COMPARISON 1: CBT+ STANDARD CARE changes global state: 2. Clinically important change (no improvement) ‐ long… compared with STANDARD CARE ALONE (very low certainty).
1 finding from 1 review
Mental state: General ‐ clinically important change (no improvement) · patients with schizophrenia
It is very uncertain whether COMPARISON 1: CBT+ STANDARD CARE changes mental state: General ‐ clinically important change (no improvement)… compared with STANDARD CARE ALONE (very low certainty).
1 finding from 1 review
Social functioning · patients with schizophrenia
1 finding from 1 review
Quality of life: 1. General quality of life · patients with schizophrenia
1 finding from 1 review
Satisfaction with treatment: 1. Leaving the study early ‐ long term · patients with schizophrenia
COMPARISON 1: CBT+ STANDARD CARE showed no clear difference in satisfaction with treatment: 1. Leaving the study early ‐ long term compared with STANDARD CARE ALONE (moderate certainty).
1 finding from 1 review
Proportion of people whose symptoms 'improved' (long term: more than 12 weeks) · symptomatic gastroparesis
It is very uncertain whether acupuncture changes proportion of people whose symptoms 'improved' (long term: more than… compared with gastrokinetic agents (very low certainty).
1 finding from 1 review
Changes of medication for gastroparesis (either short or long term) ‐ not measured · symptomatic gastroparesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life (either short or long term) ‐ not measured · symptomatic gastroparesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement in symptoms of gastroparesis (long term: more than 12 weeks) ‐ not measured · symptomatic gastroparesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of people whose symptoms 'improved' (long term: more than 12 weeks) ‐ not measured · symptomatic gastroparesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Changes of medication for gastroparesis (either short or long term) ‐ not measured · symptomatic gastroparesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement in symptoms of gastroparesis (long term: more than 12 weeks) ‐ not measured · symptomatic gastroparesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life (either short or long term) ‐ not measured · symptomatic gastroparesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found